View Cart (0 items)

Pharmaceutical

Judge denies class action suit on consumer Vioxx costs

March 18, 2009
The Associated Press reports that a New Jersey judge has rejected efforts by consumers who took the painkiller Vioxx to be able to sue as a group to recover
Read More

FDA cites bleeding risk with experimental J&J drug

March 17, 2009
The Associated Press reports that federal health officials say a Johnson & Johnson drug helps prevent deadly blood clots in patients getting hip or knee replacement surgery, but it also
Read More

Top pain scientist fabricated data in studies, hospital says

March 11, 2009
The Associated Press reports that a prominent Massachusetts anesthesiologist allegedly fabricated 21 medical studies that claimed to show benefits from painkillers like Vioxx and Celebrex, according to the hospital where
Read More

Merck buying Schering-Plough in a $41.1 billion deal

March 9, 2009
Merck & Co. is buying Schering-Plough Corp. for $41.1 billion in stock and cash in a deal that gives the companies more firepower to compete in a drug industry facing
Read More

Supreme Court rejects limits on drug lawsuits

March 4, 2009
The Supreme Court has upheld a $6.7 million jury award to a musician who lost her arm because of a botched injection of an anti-nausea medication, according to the Associated
Read More

FDA calls Glaxo ad for prostate drug ''misleading''

March 2, 2009
The Associated Press reports that a marketing campaign for a GlaxoSmithKline prostate drug has drawn complaints from federal regulators, who said the space-themed advertisement is misleading. The drugmaker''s Avodart capsules
Read More

More companies volunteering to disclose physician payments

February 24, 2009
Following years of pressure, medical device maker Medtronic Inc. will begin disclosing how much money it gives physicians in various consulting and other payments, though the reporting threshold is far
Read More

Wisconsin AG hails major victory against Pfizer unit

February 18, 2009
The attorney general for the state of Wisconsin announced that a subsidiary of Pfizer Inc. could pay more than $153 million to the state for artificially inflating prescription drug prices
Read More

Sepracor''s Lunesta targeted by generics

February 16, 2009
The Boston Business Journal reports that two competitors of drug maker Sepracor, have filed applications to produce and market generic versions of their blockbuster sleep aid Lunesta. Sepracor disclosed in
Read More

German drugmaker accused by Alabama of overpricing

February 11, 2009
An attorney for the state of Alabama told jurors that generic drug producer Sandoz Inc. set out to cheat the state''s Medicaid program with inflated prices, a claim the
Read More